Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Globus Medical Inc
(NY:
GMED
)
72.05
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
72.05
Bid (Size)
60.53 (1)
Ask (Size)
80.96 (3)
Prev. Close
72.05
Today's Range
72.05 - 72.05
52wk Range
43.38 - 74.21
Shares Outstanding
135,407,017
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
GMED Investors Have Opportunity to Join Globus Medical, Inc. Securities Fraud Investigation with the Schall Law Firm
August 21, 2024
From
The Schall Law Firm
Via
Business Wire
Globus Medical Launches ADIRA™ XLIF™ Plate System
August 21, 2024
From
Globus Medical
Via
GlobeNewswire
Performance
YTD
+35.53%
+35.53%
1 Month
+0.22%
+0.22%
3 Month
+10.02%
+10.02%
6 Month
+28.87%
+28.87%
1 Year
+33.82%
+33.82%
More News
Read More
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
August 21, 2024
Via
Chartmill
GLOBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Globus Medical, Inc. on Behalf of Globus Stockholders and Encourages Investors to Contact the Firm
August 19, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Looking Into Globus Medical's Recent Short Interest
August 19, 2024
Via
Benzinga
What 8 Analyst Ratings Have To Say About Globus Medical
August 07, 2024
Via
Benzinga
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 18, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Globus Medical, Inc. (GMED)
August 16, 2024
From
Kirby McInerney LLP
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
August 16, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
NYSE:GMED is showing decent growth, but is still valued reasonably.
July 31, 2024
Via
Chartmill
Peering Into Globus Medical's Recent Short Interest
July 25, 2024
Via
Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
August 15, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
August 15, 2024
From
Law Offices of Frank R. Cruz
Via
Business Wire
Globus Medical (GMED) Q2 2024 Earnings Call Transcript
August 06, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
Via
InvestorPlace
Where Globus Medical Stands With Analysts
July 15, 2024
Via
Benzinga
NYSE:GMED is not too expensive for the growth it is showing.
June 18, 2024
Via
Chartmill
Deep Dive Into Globus Medical Stock: Analyst Perspectives (7 Ratings)
May 29, 2024
Via
Benzinga
Globus Medical Reports Second Quarter 2024 Results
August 06, 2024
From
Globus Medical
Via
GlobeNewswire
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
July 17, 2024
From
Globus Medical
Via
GlobeNewswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
July 16, 2024
From
Globus Medical
Via
GlobeNewswire
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
July 09, 2024
Via
Chartmill
Staar Surgical Stock Earns RS Rating Upgrade
June 27, 2024
Via
Investor's Business Daily
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
June 12, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Stryker Stock Sees RS Rating Treks Higher To 71
May 29, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.